Manufacturer or GPO Program year 2025 Source: CMS Open Payments

Genmab A/S

Denmark

CMS manufacturer 100001351951

Open in the dashboard

General payments

$34,411

10 payments

Research payments

$33,318,296

6,554 payments

Ownership & investment interest

$0

None reported

Through program year 2025, Genmab A/S reported paying $34,411 in general payments and $33,318,296 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $34,061 9
2025 Research $11,609,597 3,040
2024 General $350 1
2024 Research $11,649,176 2,592
2023 Research $10,059,524 922

Breakdown

Top recipients General payments · program year 2025
  1. Ut Md Anderson Cancer Center Teaching hospital · TX $16,000 1 payment
  2. Floortje Backes Gynecologic Oncology · Hilliard, OH $9,280 3 payments
  3. Courtney Dinardo Hematology & Oncology · Houston, TX $7,125 1 payment
  4. Elizabeth Lee Internal Medicine · Boston, MA $795 1 payment
  5. Wendy Chen Physician Assistant · Houston, TX $511 2 payments
  6. Gilles Salles Hematology & Oncology · New York, NY $350 1 payment
Top research recipients Research payments · program year 2025
  1. The University Of Texas Southwestern Medical Center $1,816,797 504 payments
  2. Biomedical Research Alliance Of New York $1,336,006 295 payments
  3. Board Of Trustees Of The Leland Stanford Junior University $961,512 291 payments
  4. Memorial Sloankettering Cancer Center $887,642 292 payments
  5. University Of Alabama Hospital Teaching hospital · AL $557,185 65 payments
  6. The Ohio State University $535,156 139 payments
  7. Hackensack University Medical Center Teaching hospital · NJ $515,402 22 payments
  8. South Texas Accelerated Research Therapeutics $470,541 127 payments
  9. Cedars-Sinai Medical Center Teaching hospital · CA $416,240 179 payments
  10. National Institute Of Health $320,000 2 payments
Products the payments named General payments · program year 2025
  1. Tivdak Oncology $9,280 100% · 1 recipient

Each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

Specialties paid General payments · program year 2025
  1. Gynecologic Oncology Obstetrics & Gynecology $9,280 51% · 1 practitioner
  2. Hematology & Oncology Internal Medicine $7,475 41% · 2 practitioners
  3. Internal Medicine $795 4% · 1 practitioner
  4. Physician Assistant $511 3% · 1 practitioner

Each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Texas $23,636 69% · 3 recipients
  2. Ohio $9,280 27% · 1 recipient
  3. Massachusetts $795 2% · 1 recipient
  4. New York $350 1% · 1 recipient

Each share is of this company’s general payments in 2025 where a state was reported.

What the payments were for General payments · program years 2023–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $17,200 2 payments
  2. Consulting Fee $9,131 6 payments
  3. Travel and Lodging $8,080 2 payments
Companies with a similar name General payments · program years 2023–2025
  1. Genmab U.S., Inc. NJ, United States $4,816,660
  2. Genmab BV Netherlands $189,681

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent.

10 general · 6,554 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record